Alcon Acquired by Novartis
The merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.
Upon completion of the merger, Alcon will become the second largest division within Novartis. CIBA VISION and select Novartis ophthalmic medicines will be integrated into Alcon, forming an organization with more than $8.7 billion in sales covering over 70 percent of the eye care segment.
WASHINGTON, DC -- (Marketwire) -- 05/21/12 -- Cooley LLP announced today that Marc G. Schildkraut and Jacqueline I. Grise have joined the firm as partners in its Washington, DC office. Both were formerly partners in the antitrust practice of Dewey & LeBoeuf LLP and will join Cooley's national Antitrust and Trade Regulation Practice. Schildkraut, a former Assistant Director of the Federal Trade Commission's ("FTC") Bureau of Competition, is among the most successful and respected antitrust attorneys in the United States. He has handled the antitrust clearance aspects of some of the country's highest profile mergers transacted, including Chevron/Texaco, Exxon/Mobil, PepsiCo/Quaker, Albertson's/American Stores and Boeing/McDonnell Douglas. Schildkraut has obtained numerous ...
30 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All
